These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

143 related articles for article (PubMed ID: 37753947)

  • 1. Clinical and oncological outcomes of pelvic exenteration surgery for anal squamous cell carcinoma.
    Quyn AJ; Murthy S; Gould L; Said H; Tiernan J; Sagar P; Antoniou A; Jenkins I; Burns EM
    Colorectal Dis; 2023 Nov; 25(11):2131-2138. PubMed ID: 37753947
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Pelvic Exenteration for Anal and Urogenital Squamous Cell Carcinoma: Experience and Outcomes from an Exenteration Unit Over 12 Years.
    Smith N; Waters PS; Peacock O; Kong JC; McCormick J; Warrier SK; McNally O; Lynch AC; Heriot AG
    Ann Surg Oncol; 2020 Jul; 27(7):2450-2456. PubMed ID: 31993856
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Pelvic exenteration for recurrent squamous cell carcinoma of the pelvic organs arising from the cloaca--a single institution's experience over 16 years.
    Tan KK; Pal S; Lee PJ; Rodwell L; Solomon MJ
    Colorectal Dis; 2013; 15(10):1227-31. PubMed ID: 23714581
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Sacral resection with pelvic exenteration for advanced primary and recurrent pelvic cancer: a single-institution experience of 100 sacrectomies.
    Milne T; Solomon MJ; Lee P; Young JM; Stalley P; Harrison JD; Austin KK
    Dis Colon Rectum; 2014 Oct; 57(10):1153-61. PubMed ID: 25203370
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Pelvic Exenteration for Squamous Cell Carcinoma of the Anus: Oncological, Morbidity, and Quality-of-Life Outcomes.
    Brown KGM; Solomon MJ; Steffens D; Ng KS; Byrne CM; Austin KKS; Lee PJ
    Dis Colon Rectum; 2023 Nov; 66(11):1427-1434. PubMed ID: 37493254
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Pelvic exenteration for colorectal and non-colorectal cancer: a comparison of perioperative and oncological outcome.
    Bogner A; Fritzmann J; Müssle B; Huber J; Dobroschke J; Bork U; Wolk S; Distler M; Weitz J; Welsch T; Kahlert C
    Int J Colorectal Dis; 2021 Aug; 36(8):1701-1710. PubMed ID: 33677655
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Indications and outcome of pelvic exenteration for locally advanced primary and recurrent rectal cancer.
    Bhangu A; Ali SM; Brown G; Nicholls RJ; Tekkis P
    Ann Surg; 2014 Feb; 259(2):315-22. PubMed ID: 23478530
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The Outcomes and Patterns of Treatment Failure After Surgery for Locally Recurrent Rectal Cancer.
    Harris CA; Solomon MJ; Heriot AG; Sagar PM; Tekkis PP; Dixon L; Pascoe R; Dobbs BR; Frampton CM; Harji DP; Kontovounisios C; Austin KK; Koh CE; Lee PJ; Lynch AC; Warrier SK; Frizelle FA
    Ann Surg; 2016 Aug; 264(2):323-9. PubMed ID: 26692078
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Excellent Outcomes After Extended Radical Pelvic Resection for Locally Advanced and Recurrent IBD-Associated Anorectal Cancer.
    Chang KH; Brown KGM; Chen Lau Y; Solomon MJ
    Dis Colon Rectum; 2021 Feb; 64(2):209-216. PubMed ID: 33315717
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Feasibility of transanal minimally invasive surgery for total pelvic exenteration for advanced primary and recurrent pelvic malignancies.
    Beppu N; Ito K; Otani M; Imada A; Matsubara T; Song J; Kimura K; Kataoka K; Kuwahara R; Horio Y; Uchino M; Ikeuchi H; Ikeda M
    Tech Coloproctol; 2023 Dec; 27(12):1367-1375. PubMed ID: 37878167
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Total pelvic exenteration for primary and recurrent malignancies.
    Ferenschild FT; Vermaas M; Verhoef C; Ansink AC; Kirkels WJ; Eggermont AM; de Wilt JH
    World J Surg; 2009 Jul; 33(7):1502-8. PubMed ID: 19421811
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Pelvic exenteration: long-term oncological results in a series of 106 patients.
    De Wever I
    Acta Chir Belg; 2011; 111(5):282-7. PubMed ID: 22191128
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Factors affecting outcomes following pelvic exenteration for locally recurrent rectal cancer.
    PelvEx Collaborative
    Br J Surg; 2018 May; 105(6):650-657. PubMed ID: 29529336
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Pelvic exenteration and composite sacral resection in the surgical treatment of locally recurrent rectal cancer.
    Gawad W; Khafagy M; Gamil M; Fakhr I; Negm M; Mokhtar N; Lotayef M; Mansour O
    J Egypt Natl Canc Inst; 2014 Sep; 26(3):167-73. PubMed ID: 25150132
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Simultaneous pelvic exenteration and liver resection for primary rectal cancer with synchronous liver metastases: results from the PelvEx Collaborative.
    PelvEx Collaborative
    Colorectal Dis; 2020 Oct; 22(10):1258-1262. PubMed ID: 32294308
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Analysis on risk factors of the degree of radical resection and prognosis of patients with locally recurrent rectal cancer].
    Zhang JL; Wu T; Chen GW; Wang PY; Jiang Y; Tang JQ; Wu YC; Pan YS; Liu YC; Wan YL; Wang X
    Zhonghua Wei Chang Wai Ke Za Zhi; 2020 May; 23(5):472-479. PubMed ID: 32842427
    [No Abstract]   [Full Text] [Related]  

  • 17. Systematic Review of Pelvic Exenteration With En Bloc Sacrectomy for Recurrent Rectal Adenocarcinoma: R0 Resection Predicts Disease-free Survival.
    Sasikumar A; Bhan C; Jenkins JT; Antoniou A; Murphy J
    Dis Colon Rectum; 2017 Mar; 60(3):346-352. PubMed ID: 28177998
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Transperineal retropubic approach in total pelvic exenteration for advanced and recurrent colorectal and anal cancer involving the penile base: technique and outcomes.
    Mehta AM; Hellawell G; Burling D; Littler S; Antoniou A; Jenkins JT
    Tech Coloproctol; 2018 Sep; 22(9):663-671. PubMed ID: 30306276
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Mesorectal failure after chemoradiotherapy for squamous cell carcinoma of the anus: is sphincter-saving surgery reasonable?
    Bertrand T; Aramburu JF; Labiad C; Giacca M; Monsinjon M; Panis Y
    Tech Coloproctol; 2023 May; 27(5):379-388. PubMed ID: 36127625
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Feasibility of robotic platform to perform R0 resection for locally advanced multi-visceral pelvic malignancy: an institutional experience on outcomes of robotic pelvic exenteration.
    Saqib SU; Raza MZ; Twigg J; Altan O; Bajwa AA
    Langenbecks Arch Surg; 2023 Dec; 409(1):9. PubMed ID: 38102305
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.